141 related articles for article (PubMed ID: 33290252)
21. Flow cytometric DNA analysis of parathyroid tumors. Implication of aneuploidy for pathologic and biologic classification.
Obara T; Fujimoto Y; Kanaji Y; Okamoto T; Hirayama A; Ito Y; Kodama T
Cancer; 1990 Oct; 66(7):1555-62. PubMed ID: 2208008
[TBL] [Abstract][Full Text] [Related]
22. Angiogenesis in primary hyperparathyroidism.
Segiet OA; Michalski M; Brzozowa-Zasada M; Piecuch A; Żaba M; Helewski K; Gabriel A; Wojnicz R
Ann Diagn Pathol; 2015 Apr; 19(2):91-8. PubMed ID: 25648902
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors.
Sulaiman L; Haglund F; Hashemi J; Obara T; Nordenström J; Larsson C; Juhlin CC
PLoS One; 2012; 7(9):e46325. PubMed ID: 23029479
[TBL] [Abstract][Full Text] [Related]
24. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype.
Haven CJ; Howell VM; Eilers PH; Dunne R; Takahashi M; van Puijenbroek M; Furge K; Kievit J; Tan MH; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Dralle H; Hoang-Vu C; Gimm O; Morreau H; Marsh DJ; Teh BT
Cancer Res; 2004 Oct; 64(20):7405-11. PubMed ID: 15492263
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
26. Primary and metastatic parathyroid malignancies: a rare or underdiagnosed condition?
Shifrin A; LiVolsi V; Shifrin-Douglas S; Zheng M; Erler B; Matulewicz T; Davis J
J Clin Endocrinol Metab; 2015 Mar; 100(3):E478-81. PubMed ID: 25490272
[TBL] [Abstract][Full Text] [Related]
27. Allelic loss in parathyroid neoplasia can help characterize malignancy.
Hunt JL; Carty SE; Yim JH; Murphy J; Barnes L
Am J Surg Pathol; 2005 Aug; 29(8):1049-55. PubMed ID: 16006799
[TBL] [Abstract][Full Text] [Related]
28. Aberrant WNT/β-catenin signaling in parathyroid carcinoma.
Svedlund J; Aurén M; Sundström M; Dralle H; Akerström G; Björklund P; Westin G
Mol Cancer; 2010 Nov; 9():294. PubMed ID: 21078161
[TBL] [Abstract][Full Text] [Related]
29. Genetic profiling as a clinical tool in advanced parathyroid carcinoma.
Kutahyalioglu M; Nguyen HT; Kwatampora L; Clarke C; Silva A; Ibrahim E; Waguespack SG; Cabanillas ME; Jimenez C; Hu MI; Sherman SI; Kopetz S; Broaddus R; Dadu R; Wanland K; Williams M; Zafereo M; Perrier N; Busaidy NL
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1977-1986. PubMed ID: 31309300
[TBL] [Abstract][Full Text] [Related]
30. Profiling analysis of long non-coding RNA and mRNA in parathyroid carcinoma.
Zhang X; Hu Y; Wang M; Zhang R; Wang P; Cui M; Su Z; Gao X; Liao Q; Zhao Y
Endocr Relat Cancer; 2019 Feb; 26(2):163-176. PubMed ID: 30403657
[TBL] [Abstract][Full Text] [Related]
31. Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology.
Forsberg L; Björck E; Hashemi J; Zedenius J; Höög A; Farnebo LO; Reimers M; Larsson C
Eur J Endocrinol; 2005 Mar; 152(3):459-70. PubMed ID: 15757864
[TBL] [Abstract][Full Text] [Related]
32. Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review.
Dai C; Liang S; Sun B; Li Y; Kang J
Front Oncol; 2021; 11():773905. PubMed ID: 34869016
[TBL] [Abstract][Full Text] [Related]
33. Unique expression pattern of the EMT markers Snail, Twist and E-cadherin in benign and malignant parathyroid neoplasia.
Fendrich V; Waldmann J; Feldmann G; Schlosser K; König A; Ramaswamy A; Bartsch DK; Karakas E
Eur J Endocrinol; 2009 Apr; 160(4):695-703. PubMed ID: 19176646
[TBL] [Abstract][Full Text] [Related]
34. A microRNA signature for the differential diagnosis of salivary gland tumors.
Denaro M; Navari E; Ugolini C; Seccia V; Donati V; Casani AP; Basolo F
PLoS One; 2019; 14(1):e0210968. PubMed ID: 30682201
[TBL] [Abstract][Full Text] [Related]
35. Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease.
Tominaga Y; Tsuzuki T; Matsuoka S; Uno N; Sato T; Shimabukuro S; Goto N; Nagasaka T; Uchida K
World J Surg; 2008 May; 32(5):815-21. PubMed ID: 18338208
[TBL] [Abstract][Full Text] [Related]
36. Integrated Whole-Exome and Transcriptome Sequencing of Sporadic Parathyroid Adenoma.
Hu Y; Zhang X; Wang O; Cui M; Li X; Wang M; Hua S; Liao Q
Front Endocrinol (Lausanne); 2021; 12():631680. PubMed ID: 34054720
[TBL] [Abstract][Full Text] [Related]
37. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway.
Dong G; Loukinova E; Chen Z; Gangi L; Chanturita TI; Liu ET; Van Waes C
Cancer Res; 2001 Jun; 61(12):4797-808. PubMed ID: 11406555
[TBL] [Abstract][Full Text] [Related]
38. Parathyroid Carcinoma.
Cetani F; Pardi E; Marcocci C
Front Horm Res; 2019; 51():63-76. PubMed ID: 30641523
[TBL] [Abstract][Full Text] [Related]
39. Parathyroid cancer.
Sharretts JM; Kebebew E; Simonds WF
Semin Oncol; 2010 Dec; 37(6):580-90. PubMed ID: 21167377
[TBL] [Abstract][Full Text] [Related]
40. Transcryptomic Analysis of Human Brain -Microvascular Endothelial Cell Driven Changes in -Vascular Pericytes.
Kurmann L; Okoniewski M; Dubey RK
Cells; 2021 Jul; 10(7):. PubMed ID: 34359953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
